LIFE SCIENCES

LIFE SCIENCES, MANUFACTURING, SUPPLY CHAIN

Interview – Shane Yount on Leadership, Performance, and Developing Your Team

April 27, 2017

Shane Yount, Principal and Author with Competitive Solutions, sat down for a few minutes at the 2017 edition of the North American Manufacturing Excellence Summit. Be sure to also watch Shane’s full workshop presentation, “Business Bootcamp – Driving Greater Execution, Engagement, and Ultimately Earnings!” for more insights.

—

Shane A. Yount is a nationally recognized author, consultant, and principal of Competitive Solutions, Inc., an international Business Transformation consulting and software firm. Shane’s team pioneered the acclaimed organizational governance system known as Process Based Leadership® (PBL) – A robust governance methodology designed to create a sustainable cadence of clarity, connectivity, and consistency. Shane’s ability to diagnose inefficient governance models and quickly design and deploy solutions that accelerate and amplify team performance has made him and his firm long-term partners with such organizations as Genentech, Pfizer, Alcon, Roche, GSK, Meridian Medical Technologies, and many others. Since 1991, Shane has led the offices of Competitive Solutions, Inc. while publishing three best-selling business novels. His latest novel, Leading Your Business Forward is required reading within many leadership development curriculums being taught within industry today.

by EPadmin

Business Bootcamp – Driving Greater Execution, Engagement, and Ultimately Earnings!

April 27, 2017

At NAMES17, Shane Yount of Competitive Solutions asked his audience, “Are you ready to accurately assess your teams, your leaders, and your performance?”

For 25 years, Competitive Solutions, Inc. has been taking organizations through Business Bootcamp with some pretty dramatic results. Learn how to:

Drive Business Acumen at a tactical level
Move accountability from a concept to a practice and elevate expectations of engagement
Eliminate hours of meetings a week by recalibrating intent
Moving from abstract OPEX tools to business critical necessities
What are the eight essential elements of 21st century leaders?

by EPadmin

1 Comment

Impacts of Cultural Change in Under-Performing Facilities

April 25, 2017

Michael Brice, VP Offset Operations at INX International Ink Co., led a roundtable lunch-and-learn discussion entitled, “Impacts of Cultural Change in Under-Performing Facilities” at the 2017 edition of the North American Manufacturing Excellence Summit. In this video he shares why he chose this topic and how the lunch conversation went.

—

Michael Brice is a 31-year printing ink industry veteran. He has served in every capacity: lab technician, colormatching, manufacturing, inplant technician and management, sales and senior level management. Mike became Chief Operating Officer of Superior Printing Inks in 2000 and named is President and COO in 2003. He also worked in the energy sector and then for Squid Ink Manufacturing for two years until he joined INX International Ink Company in Nov, 2011. Michael has served INX in a sales capacity as well as organizing and managing INX’s North American distribution effort. Mike was appointed Director of Offset Operations in 2012 and then, his current position, as Vice President of Offset Operations in 2013.

by EPadmin

Generate Value from Plant Floor Data with AI and the Digital Twin

April 25, 2017

In this interview Syed Hoda, Sight Machine’s CMO, discusses how AI and digital twins are making plant floor data useful to manufacturers in whole new ways.

—

Syed Hoda has served in leadership roles, on three different continents, at both start-up and large technology companies, including Cisco, Scality, ParStream, and IBM. Syed received an MBA from Emory University and an undergraduate in Industrial Engineering from Case Western Reserve University.

by EPadmin

Digital Transformation with Business Impact for Manufacturers

March 16, 2017

Chris Dobbrow, the Senior Vice President of Sight Machine, spoke at the Biomanufacturing World Summit in San Diego, CA in November 2016. His presentation was entitled:

Digital Transformation with Business Impact for Manufacturers

Proving that the most valuable data in manufacturing is from production itself
Choosing the right goals and outcomes to make a difference
Connecting disparate IT systems together into a unified whole
Building a scalable approach for the enterprise, step-by-step: Start small to go big
Understanding why data lakes and bespoke projects don’t scale
Illustrating successful projects with concrete examples

by EPadmin

Bringing a Quality Focus to CMO Management

March 6, 2017

Walter Cespedes led a roundtable lunch and learn discussion about bringing a quality focus to CMO management at the 2016 edition of the Biomanufacturing World Summit. We asked him a few questions about how it went.

—

Walter Cespedes is a seasoned executive with over 28 years of industry Quality experience. Mr. Cespedes serves as Executive Director, Third Party and Commercial Quality Americas for Teva (Actavis). Prior to this appointment, he served as VP Corporate Quality for Durata Therapeutics, Inc. Mr. Cespedes has also held a position as a Senior Director of Corporate Quality Assurance for MEDA Pharmaceuticals. Prior to his work at MEDA, he held Quality Assurance roles at Pfizer, such as Quality Operations Supervisor, Senior Manager for Quality Operations, and Drug Product Assurance Team Leader. Earlier in his career, he worked for Roche Diagnostic Systems, Inc., Hoffman La-Roche, Inc, and Biocraft Laboratories, Inc. Mr. Cespedes is a graduate of Seton Hall University and earned his Masters of Science in Executive Management from the New Jersey Institute of Technology. He now serves on the board of NJIT College of Science & Liberal Arts.

by EPadmin

The Role of Manufacturing in a Successful Biosimilar Strategy

February 16, 2017

Peter Moesta spoke on November 15th at the 2016 edition of the Biomanufacturing World Summit. His keynote presentation was entitled, The Role of Manufacturing in a Successful Biosimilar Strategy.

—

Peter Moesta has more than 30 years of experience in the biopharmaceutical industry and a strong understanding of manufacturing and launching complex biologics. Before joining TPI, he was senior vice president of Biologics Manufacturing at Bristol-Myers Squibb, where he oversaw the development, production and worldwide launch of numerous significant biologics, including oncology products Yervoy and Opdivo. Previous to this role, Peter held various leadership positions in biologics development and manufacturing at Abbott Laboratories and BASF AG.

by EPadmin

Bringing Virtual Reality Tools to Biopharmaceutical Manufacturers

February 13, 2017

Michelle Stafford of GE Healthcare demonstrated new virtual reality tools at the Biomanufacturing World Summit. Executives were able to tour a facility in China and step inside a bioreactor to inspect its internal workings. Will these new tools become an industry standard in the near future?

—

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.

Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more
people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world.

by EPadmin

How Companies and Communities Find Success Together

February 13, 2017

Frank McCrady attended the 2016 edition of the Biomanufacturing World Summit. In this interview, he shares some of his thoughts about what companies are looking for when they are evaluating where they want to do business and who they want to do business with.

—

With nearly 30 years of experience in economic development and banking, Frank McCrady has spent 14 of those years as EMCID’s President and CEO, elevating East Montgomery County through strategic planning to a community ready for growth. Under his leadership, development has soared and sales tax revenue for the 158-square mile improvement district has increased by more than 200 percent, from $2.5 million in 2002 to $7.7 million in 2015. Current retail and entertainment projects underway stand to further financial success for the District and the community in the form of job creation, additional business recruiting tools, expanded services, community grants and scholarships for local youth.

McCrady was elected in November 2015 to serve as the Western Region Director of the Southern Economic Development Council (SEDC), the oldest and largest regional economic development association in North America. The SEDC is comprised of 17 states in the southern United States and the District of Columbia. As Western Region Director, McCrady will lend a strong voice for economic leadership to Arkansas, Kansas, Louisiana, Missouri, Oklahoma and Texas. This is the second time McCrady has been elected to the position; he served a one-year term in 2008.

Prior to taking over the leadership position at EMCID, McCrady served as the Deputy Director of Community and Economic Development for Salt Lake City, the Executive Director of the Tulsa Economic Development Corporation and as Operations Manager of Riggs National Bank in Washington, D.C. He also served in the U.S. Army Reserve and retired as a lieutenant colonel after 28 years.

McCrady graduated from the University of Arkansas with a BS in Finance and Banking. He received his MBA from Webster University in St. Louis, MO. McCrady also attended the United States Command and General Staff College in Fort Leavenworth, KS and took the Advanced Operations and Warfighter course, completed studies at the United States Army War College in Pennsylvania, and he took on additional coursework at the National Defense University in Washington, D.C.

by EPadmin

A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build

December 19, 2016

David Radspinner spoke on November 14th at the 2016 edition of the Biomanufacturing World Summit. His session was entitled, A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build.

In March 2016, David Radspinner was appointed as the General Manager for the GEHC LS newly created BioPark business.

Previously, in January of 2014, GE acquired the HyClone Cell Culture business and subsequently David was appointed as its Hold Separate Manager.

David earned a PhD in Analytical Chemistry from the University of Arizona and has spent over 14 years working within the areas of developing, manufacturing and characterizing pharmaceuticals. David has over 10 years experience in business development, product management, sales, marketing and cross-functional leadership.

by EPadmin

The Role of Process Development in Next Generation Biologics Manufacturing

December 13, 2016

Alison Moore delivered the opening keynote on November 15th of the 2016 edition of the Biomanufacturing World Summit entitled, The Role of Process Development in Next Generation Biologics Manufacturing.

Dr. Alison Moore is Senior Vice President, Process Development serving both Operations and R&D organizations. Prior to this role, Moore served as senior vice president, Operations Technology. Moore was previously vice president, Process and Product Engineering (P&PE) function, where she was responsible for Process Development, Clinical Operations and Global Operations Planning. Moore served as vice president, Corporate Manufacturing, overseeing Supply Chain, Contract Manufacturing, Global Distribution, Manufacturing Technologies, and Operations Risk Management. Before taking on this position, she was vice president, Site Operations at Amgen’s Fremont, California, manufacturing facility (AFR).

Before heading up the AFR facility, Moore was a director in Chemistry, Manufacturing and Controls Regulatory Affairs at Genentech. Prior to her time at Genentech, Moore had previously spent nine years at Amgen in various positions of increasing responsibility within the Process Development organization.

Moore holds a Ph.D. in Cell Biology from Manchester University, England, and a bachelor’s in Pharmacology with Honors from Manchester University, England. Following her doctoral degree work at Manchester University, she was a Postdoctoral Research Fellow at the Medical University of Lübeck, Germany, and at Genentech.

by EPadmin

Speaker Sit Down: Tim Moore – Genentech

March 14, 2016

by EPadmin

Sponsors Corner: Dean Ocampo – Elementum

March 9, 2016

Dean Ocampo who is the Director of Product Marketing from Elementum, speaks about some of the company’s new offerings and his key takeaways from the Biomanufacturing World Summit.

by EPadmin

Speaker Sit Down: Anders Vinther – Sanofi Pasteur

March 9, 2016

We had a chance to speak with one of our keynote speakers Anders Vintner who is the Chief Quality Officer at Sanofi Pasteur to get some of his thoughts about the state of the industry and his key takeaways from the Biomanufacturing World Summit.

by EPadmin